Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QNext and DG-PT

K-Number: K183390 · 2019-08-21

Decision Date2019-08-21
Product CodeJPA
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

QNext and DG-PT is a medical device manufactured by Diagnostic Grifols, S.A.. It received FDA 510(k) clearance on 2019-08-21 under approval number K183390. The device is classified under product code JPA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QNext and DG-PT?

QNext and DG-PT is a medical device that received FDA 510(k) clearance on 2019-08-21. It is manufactured by Diagnostic Grifols, S.A.. The 510(k) number is K183390.

When was QNext and DG-PT approved by the FDA?

QNext and DG-PT received FDA 510(k) clearance on 2019-08-21, under approval number K183390.

What company makes QNext and DG-PT?

QNext and DG-PT is manufactured by Diagnostic Grifols, S.A..

What is the FDA product code for QNext and DG-PT?

The FDA product code for QNext and DG-PT is JPA.

Related Devices (Code: JPA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.